# US 2020/0139074 A1 · Combination devices, systems, and methods for humidification of the airways and high efficiency delivery of pharmaceutical aerosols

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0139074 A1
- Document ID: US20200139074A1
- Status: Published application
- Kind: A1
- Application number: 16/617,541
- Filed: 2018-05-31
- Published: 2020-05-07
- Earliest claimed: 2017-05-31
- Assignees: Virginia Commonwealth University
- Applicants: Virginia Commonwealth University
- Inventors: Philip Worth LONGEST, JR.; Michael HINDLE; Benjamin SPENCE; Sneha DHAPARE; Wei XIANGYIN
- Web page: https://patentgrep.com/patent/US20200139074A1

## CPC

- A61M 16/14: by mixing different fluids, one of them being in a liquid phase
- A61M 11/041: {using heaters}
- A61M 15/0086: {Inhalation chambers}
- A61M 16/0666: {Nasal cannulas or tubing (devices for improving normal breathing through the nose A61F5/08; nose filters A62B23/06; outside holding devices A61M25/02)}
- A61M 16/0816: {Joints or connectors}
- A61M 16/1085: {after being humidified or mixed with a beneficial agent}
- A61M 16/16: Devices to humidify the respiration air {(A61M16/1045 takes precedence)}
- A61M 11/00: Sprayers or atomisers specially adapted for therapeutic purposes (in general B05B; {aerosol containers B65D83/14})
- A61M 16/024: {including calculation means, e.g. using a processor}
- A61M 2016/0018: {electrical}
- A61M 2205/0238: the material being a coating or protective layer
- A61M 2205/3368: Temperature
- A61M 2206/11: Laminar flow
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Devices, systems, and methods are disclosed which permit ventilation therapy concurrent with humidity and aerosol drug delivery. Exemplary mixer-heaters employ alternating actuation of humidity and drug nebulizers and may use a single constant power setting for the heating section while keeping a controlled outlet temperature over the course of treatment.

## Claims

### Claim 1

A drug delivery system, comprising
a first nebulizer configured to intermittently produce a humidity stream;
a second nebulizer configured to intermittently produce a drug aerosol stream, wherein the first and second nebulizers are configured to actuate in alternating intervals;
a mixer-heater comprising
a mixing section configured to combine the humidity stream and the drug aerosol stream with a ventilation stream to produce a combination stream, and
a heating section configured to be operated at a constant power setting without heating the combination stream above 42° C.;
a patient interface configured for delivering the combination stream to a patient; and
one or more conduits fluidically connecting the mixer-heater with the patient interface;
wherein a volume of the mixer-heater, a volume of the one or more conduits, and a volume of the patient interface add up to a system volume of 150 mL or less.

### Claim 2 (depends on 1)

The drug delivery system of claim 1, wherein drug delivery system is configured to deliver a constant combination stream to the patient over a single course of patient treatment.

### Claim 3 (depends on 2)

The drug delivery system of claim 2, wherein the patient interface is a nasal cannula, and wherein the single course of patient treatment is high flow nasal cannula therapy (HFNC).

### Claim 4 (depends on 1)

The drug delivery system of claim 1, further comprising a controller configured to regulate the first nebulizer, second nebulizer, and heating section.

### Claim 5 (depends on 1)

The drug delivery system of claim 1, wherein the system volume is 40 ml or less.

### Claim 6 (depends on 1)

The drug delivery system of claim 1, further comprising a flow unifier configured to modify the ventilation stream prior to the ventilation stream's admission to the mixing section of the mixer-heater.

### Claim 7 (depends on 6)

The drug delivery system of claim 6, wherein the flow unifier comprises a three-dimensional rod array.

### Claim 8 (depends on 1)

The drug delivery system of claim 1, wherein the heating section is configured to be operable such that outlet temperature is maintained in a range of 27 to 42° C.

### Claim 9 (depends on 1)

The drug delivery system of claim 1, wherein the heating section is configured to be operable such that outlet temperature is maintained in a range of 28 to 37° C.

### Claim 10 (depends on 1)

The drug delivery system of claim 1, wherein the heating section is configured to be operable such that outlet temperature is maintained in a range of 32±2° C.

### Claim 11

A method of drug delivery with ventilation therapy, comprising
intermittently producing a humidity stream with a first nebulizer;
intermittently producing a drug aerosol stream with a second nebulizer, wherein the humidity stream and drug aerosol stream are produced in alternating intervals; with a mixer-heater,
mixing the humidity stream and the drug aerosol stream with a ventilation stream to produce a combination stream, and
heating the combination stream to a temperature not exceeding 42° C. with a heating section operated at a constant power setting; and
delivering the combination stream to a patient using a patient interface and one or more conduits,
wherein the combining, mixing, heating, and delivering steps use 150 mL or less total system volume.

### Claim 12 (depends on 11)

The method of claim 11, wherein the step of delivering comprises delivering a constant combination stream to the patient over a single course of patient treatment.

### Claim 13 (depends on 12)

The method of claim 12, wherein the patient interface is a nasal cannula, and wherein the single course of patient treatment is high flow nasal cannula therapy (HFNC).

### Claim 14 (depends on 11)

The method of claim 11, further comprising regulating the first nebulizer, second nebulizer, and heating section with a controller.

### Claim 15 (depends on 11)

The method of claim 11, wherein the system volume is 40 ml or less.

### Claim 16 (depends on 11)

The method of claim 11, further comprising modifying the ventilation stream with a flow unifier prior to the ventilation stream's admission to the mixing section of the mixer-heater.

### Claim 17 (depends on 16)

The method of claim 16, wherein the flow unifier comprises a three-dimensional rod array.

### Claim 18 (depends on 11)

The method of claim 11, wherein the step of heating heats the combination stream to an outlet temperature in a range of 27 to 42° C.

### Claim 19 (depends on 11)

The method of claim 11, wherein the step of heating heats the combination stream to an outlet temperature in a range of 28 to 37° C.

### Claim 20 (depends on 11)

The method of claim 11, wherein the step of heating heats the combination stream to an outlet temperature in a range of 32±2° C.
